Latest News about REGN
Recent news which mentions REGN
JP Morgan Maintains Overweight Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
March 31, 2023
Tickers
REGN
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug
March 27, 2023
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Baird Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
March 24, 2023
Tickers
REGN
From Benzinga
Wall Street Has High Hopes for These 2 Nasdaq Stocks
March 24, 2023
From Motley Fool
From Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
March 24, 2023
Tickers
REGN
From Benzinga
Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
March 24, 2023
From Benzinga
Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration
March 24, 2023
From Benzinga
US Stocks On Track For Weak Start Friday Amid Renewed Banking Concerns And Contagion Fears
March 24, 2023
From Benzinga
Why Shares of Regeneron Are Rising Thursday
March 23, 2023
From Motley Fool
Why Are Stocks Up Today?
March 23, 2023
From InvestorPlace
From InvestorPlace
This Is What Whales Are Betting On Regeneron Pharmaceuticals
March 23, 2023
Tickers
REGN
From Benzinga
From Benzinga
From Benzinga
Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move
March 23, 2023
From MarketWatch
7 Value Stocks Worth Buying at These 52-Week Highs
March 22, 2023
From InvestorPlace
Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
March 22, 2023
From MarketWatch
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.